Search
SAB Biotherapeutics Inc
SABSAdd to Watchlist
3.570USD
+0.010+0.28%
Close 07-31 16:00（ET）Quotes delayed by 15 min
272.98MMarket Cap
8.35P/E TTM
SAB Biotherapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of SAB Biotherapeutics Inc is 6.50, ranking 291 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 8.35, which is 149.18% below the recent high of 20.80 and 206.87% above the recent low of -8.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.